HilleVax, Inc. (HLVX)
NASDAQ: HLVX · Real-Time Price · USD
1.950
+0.020 (1.04%)
At close: May 2, 2025, 4:00 PM
1.990
+0.040 (2.05%)
After-hours: May 2, 2025, 4:47 PM EDT
HilleVax Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for HilleVax stock have an average target of 2.33, with a low estimate of 2.00 and a high estimate of 3.00. The average target predicts an increase of 19.49% from the current stock price of 1.95.
Analyst Consensus: Hold
* Price targets were last updated on Mar 31, 2025.
Analyst Ratings
The average analyst rating for HilleVax stock from 5 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 5 | 5 | 5 | 5 | 5 | 5 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $2 | Hold | Reiterates | $2 | +2.56% | Mar 31, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $2 | Hold | Reiterates | $2 | +2.56% | Aug 12, 2024 |
Leerink Partners | Leerink Partners | Buy → Hold Downgrades $28 → $2 | Buy → Hold | Downgrades | $28 → $2 | +2.56% | Jul 9, 2024 |
Stifel | Stifel | Strong Buy → Hold Downgrades $34 → $3 | Strong Buy → Hold | Downgrades | $34 → $3 | +53.85% | Jul 9, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jul 9, 2024 |
Financial Forecast
Revenue This Year
n/a
from 62.00M
Revenue Next Year
n/a
EPS This Year
-1.39
from -3.00
EPS Next Year
-1.36
from -1.39
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | n/a | n/a | n/a | ||
Avg | n/a | n/a | n/a | ||
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -1.09 | -1.14 | -1.41 | ||
Avg | -1.39 | -1.36 | -1.43 | ||
Low | -1.65 | -1.54 | -1.44 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.